IT8322012A0 - Composizioni farmaceutiche dermiche ad azione prolungata e continua, a base di acidi grassi essenziali. - Google Patents

Composizioni farmaceutiche dermiche ad azione prolungata e continua, a base di acidi grassi essenziali.

Info

Publication number
IT8322012A0
IT8322012A0 IT8322012A IT2201283A IT8322012A0 IT 8322012 A0 IT8322012 A0 IT 8322012A0 IT 8322012 A IT8322012 A IT 8322012A IT 2201283 A IT2201283 A IT 2201283A IT 8322012 A0 IT8322012 A0 IT 8322012A0
Authority
IT
Italy
Prior art keywords
dermic
lasting
long
fatty acids
pharmaceutical compositions
Prior art date
Application number
IT8322012A
Other languages
English (en)
Other versions
IT1169745B (it
Inventor
Pierre Richard Dick
Original Assignee
Dick P R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dick P R filed Critical Dick P R
Publication of IT8322012A0 publication Critical patent/IT8322012A0/it
Application granted granted Critical
Publication of IT1169745B publication Critical patent/IT1169745B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT22012/83A 1983-06-29 1983-07-12 Composizioni farmaceutiche dermiche ad azione prolungata e continua,a base di acidi grassi essenziali IT1169745B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8310735A FR2548021B1 (fr) 1983-06-29 1983-06-29 Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels

Publications (2)

Publication Number Publication Date
IT8322012A0 true IT8322012A0 (it) 1983-07-12
IT1169745B IT1169745B (it) 1987-06-03

Family

ID=9290290

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22012/83A IT1169745B (it) 1983-06-29 1983-07-12 Composizioni farmaceutiche dermiche ad azione prolungata e continua,a base di acidi grassi essenziali

Country Status (10)

Country Link
US (1) US4710383A (it)
JP (1) JPS6023315A (it)
CA (1) CA1205016A (it)
CH (1) CH657988A5 (it)
DE (1) DE3325130A1 (it)
ES (1) ES8500561A1 (it)
FR (1) FR2548021B1 (it)
GB (1) GB2142234B (it)
IT (1) IT1169745B (it)
NL (1) NL8302455A (it)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
GB8420771D0 (en) * 1984-08-15 1984-09-19 Efamol Ltd Treatment of skin disorders
FR2581310B1 (fr) * 1985-05-02 1988-09-23 Natura Medica Laboratoires Composition therapeutique comportant de l'acide a-linolenique et un compose susceptible de favoriser le passage de l'acide au travers de la membrane cellulaire et extrait de plantes comprenant l'acide et le compose
GB8527071D0 (en) * 1985-11-04 1985-12-11 Biocompatibles Ltd Plastics
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
DE3719097C1 (de) * 1987-06-06 1988-06-09 Fratzer Uwe Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E
JPS647632A (en) * 1987-06-30 1989-01-11 Hitachi Ltd Inspection device for semiconductor element
JPS646043U (it) * 1987-06-30 1989-01-13
IT1223290B (it) * 1987-07-27 1990-09-19 Indena Spa Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
US5028431A (en) * 1987-10-29 1991-07-02 Hercon Laboratories Corporation Article for the delivery to animal tissue of a pharmacologically active agent
DE68924714T2 (de) * 1988-01-14 1996-05-02 Anders Frithz Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
DE3814047C1 (en) * 1988-04-26 1989-11-16 Fratzer, Antje-Mandy, 6719 Hettenleidelheim, De Composition for the treatment of multiple sclerosis
GB2218904A (en) * 1988-05-27 1989-11-29 Renafield Limited Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid
IL92496A0 (en) * 1988-12-01 1990-08-31 Schering Corp Compositions for transdermal delivery of estradiol
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
CA2082418A1 (en) * 1990-05-07 1991-12-28 Barry I. Bockow Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
DE4022815A1 (de) * 1990-07-18 1992-01-23 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen
DE4042437A1 (de) * 1990-07-18 1992-06-11 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen
DE4133694C2 (de) * 1991-10-11 1993-10-07 Fresenius Ag Verwendung einer Emulsion mit mehrfach ungesättigten Fettsären zur i.v.-Verabreichung zur Behandlung von Hauterkrankungen
DE4323174C2 (de) * 1993-07-10 1995-09-14 Rhone Poulenc Rorer Gmbh Pharmazeutische und/oder kosmetische Zubereitung
NL9201438A (nl) * 1992-08-11 1994-03-01 Prospa Bv Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen.
DE4238869C2 (de) * 1992-11-18 1994-09-08 Wogepharm Gmbh Mittel zur Behandlung des atopischen Ekzems und anderer entzündlicher Hautkrankheiten
US5443844A (en) * 1992-12-03 1995-08-22 Mcdaniel; William R. Linoleic acid preparations for topical treatment of acne vulgaris
DE4313402A1 (de) * 1993-04-23 1994-10-27 Hexal Pharma Gmbh Transdermale Wirkstoffzubereitung
DE4330664A1 (de) * 1993-09-10 1995-03-16 Beiersdorf Ag Verwendungen von Pflanzenölen
DE4432633C2 (de) * 1994-09-14 1997-07-31 Singer Peter Dr Med Priv Doz Pharmazeutisches Präparat zur lokalen Behandlung von Schuppenflechte, Neurodermitis und Ekzem
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20050090433A1 (en) 2002-11-18 2005-04-28 Vicuron Pharmaceuticals, Inc Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
ES2452733T3 (es) 2004-05-28 2014-04-02 Abbvie Deutschland Gmbh & Co Kg Forma de dosificación obtenible a partir de una mezcla pulverulenta que comprende un pigmento inorgánico
BRPI0501708A (pt) * 2005-05-10 2007-05-02 Jean Marc Millet dispositivo de liberação lenta por processo transdérmico de um medicamento contra o excesso de colesterol e método de produção de um dispositivo transdérmico
GB0808479D0 (en) * 2008-05-09 2008-06-18 Uni I Oslo Topical compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB951418A (en) * 1960-11-25 1964-03-04 Smith Kline French Lab Improvements in or relating to a method of preparing high dosage sustained release tablet and product of this method
BE640616A (it) * 1962-12-19
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
US3574826A (en) * 1968-02-27 1971-04-13 Nat Patent Dev Corp Hydrophilic polymers having vitamins absorbed therein
FR1605150A (it) * 1968-12-31 1973-03-16
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
US4150109A (en) * 1974-05-07 1979-04-17 Dick Pierre R G Devices for protecting animals from ectoparasites
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
DE2755224A1 (de) * 1976-12-15 1978-07-13 Procter & Gamble Schmerzen und entzuendungen linderndes mittel zur oertlichen anwendung
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
AU527784B2 (en) * 1978-05-26 1983-03-24 Bang, Hans Olaf Dr. Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
DE2942021A1 (de) * 1979-10-17 1981-04-30 Bristol Myers Co Dermatologisches mittel
FR2474310A1 (fr) * 1980-01-25 1981-07-31 Oreal Solution stable a l'oxydation de vitamine f et d'huile de jojoba et compositions cosmetiques la contenant
DE3152174A1 (de) * 1980-06-27 1982-08-12 Nippon Oils & Fats Co Ltd Thrombosis-prophylatic and curing agent
CA1163559A (en) * 1980-07-09 1984-03-13 Alec D. Keith Polymeric diffusion matrix for administration of drugs
DE3039881A1 (de) * 1980-10-22 1982-05-27 Bayer Ag, 5090 Leverkusen Ektroparasitizidhaltige halsbaender fuer haustiere
DE3039882A1 (de) * 1980-10-22 1982-05-27 Bayer Ag, 5090 Leverkusen Ektoparasitizidhaltige polyurethane

Also Published As

Publication number Publication date
JPS6023315A (ja) 1985-02-05
GB2142234A (en) 1985-01-16
CH657988A5 (fr) 1986-10-15
ES524032A0 (es) 1984-11-01
DE3325130A1 (de) 1985-01-03
IT1169745B (it) 1987-06-03
FR2548021A1 (fr) 1985-01-04
US4710383A (en) 1987-12-01
GB8318564D0 (en) 1983-08-10
CA1205016A (fr) 1986-05-27
ES8500561A1 (es) 1984-11-01
FR2548021B1 (fr) 1986-02-28
GB2142234B (en) 1987-07-08
NL8302455A (nl) 1985-01-16

Similar Documents

Publication Publication Date Title
IT8322012A0 (it) Composizioni farmaceutiche dermiche ad azione prolungata e continua, a base di acidi grassi essenziali.
IT8721453A0 (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche.
IT8921521A0 (it) Composizione di acidi grassi.
BR9006960A (pt) Composicoes farmaceuticas e cosmeticas despigmentantes a base de acido cafeico
ATA18688A (de) Mundpflegemittel
AT397765B (de) Mundpflegemittel
ATA237586A (de) Mundpflegemittel
AT400000B (de) Mundpflegemittel
IT1227165B (it) Dipeptidi fosfinilcicloalchilcarbonilici e fosfonilcicloalchenilcarbonilici ad azione farmaceutica
NL190241C (nl) Thermoplastische samenstellingen en daarop gebaseerde voortbrengselen.
ATA36088A (de) Regalfoerderzeug
IT8621393A1 (it) Composizioni farmaceutiche ad azione vasodilatatrice ed antianossica
BE876238A (fr) Derives d'isopropylbenzene et leur preparation
IT8867667A0 (it) Composizioni farmaceutiche e cosmetiche a base di piridone e di agenti antibatterici
FR2624012B1 (fr) Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
NZ184394A (en) N-acyl-l-alanyl -aminoacyl-amides intermediates and pharmaceutical compositions
BE855287A (fr) Compositions pharmaceutiques et cosmetiques a base d'elastine
BE863137A (fr) Compositions pharmaceutiques a base d'acides alpha-mercapto-beta-arylacryliques
DE3880307D1 (de) Perfluoralkene und fluorierungsprodukte davon.
FR2584294B1 (fr) Compositions pharmaceutiques a visee cytotrophique
DE3781045D1 (de) Antirheumatisches arzneimittel.
NL7701144A (nl) Benzamiden en daarop gebaseerde geneesmiddelen met monoaminooxydase-remmende werking.
IT7823949A0 (it) Composizioni farmaceutiche e cosmetiche a base di elastina.
FR2573653B1 (fr) Compositions pharmaceutiques antiandrogenes a base d'acides gras
IT1202914B (it) Composto a base di s-adenosil-l-omocisteina avente attivita' farmaceutica quale sedativo e induttore di sonno e composizioni farmaceutiche contenenti il medesimo